Literature DB >> 26523066

A new clinical guideline from the Royal College of Paediatrics and Child Health with a national awareness campaign accelerates brain tumor diagnosis in UK children--"HeadSmart: Be Brain Tumour Aware".

.   

Abstract

BACKGROUND: A national survey in 2006 identified that UK referral practice for pediatric CNS tumors ranked poorly in international comparisons, which led to new National Health Service (NHS) Evidence accredited referral guidelines published in 2008 by the Royal College of Paediatrics and Child Health and a campaign to raise awareness of early features of CNS tumors and the need for timely imaging.
METHODS: The "HeadSmart: Be Brain Tumour Aware" campaign was launched in June 2011 across the UK as a quality improvement strategy directed at reducing the total diagnostic interval (TDI) from a pre-campaign (2006) median of 14 (mean, 35.4) weeks to a target of 5 weeks in order to equal the best reported internationally. Professional and public awareness was measured by questionnaire surveys. TDI was collected by clinical champions in 18 regional children's cancer centers and the public campaign was coordinated by a national charity, working with a network of community champions.
RESULTS: The guidelines and campaign raised awareness among pediatricians and were associated with reduction in TDI to a median of 6.7 (mean, 21.3) weeks by May 2013. This change in referral practice was most pronounced in the time from first medical contact to CNS imaging, for which the median was reduced from 3.3 to 1.4 weeks between January 2011 and May 2013 (P = .009).
CONCLUSION: This strategy to accelerate brain tumor diagnosis by the NHS using a public and professional awareness campaign is a "world first" in pediatric cancer and is being emulated internationally and acknowledged by a series of NHS and charity awards for excellence. © Crown copyright 2015.

Entities:  

Keywords:  awareness campaign; diagnostic delay; pediatric brain tumour; total diagnostic interval

Mesh:

Year:  2015        PMID: 26523066      PMCID: PMC4767243          DOI: 10.1093/neuonc/nov187

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  11 in total

1.  Risk of childhood cancer with symptoms in primary care: a population-based case-control study.

Authors:  Rachel M Dommett; Theresa Redaniel; Michael C G Stevens; Richard M Martin; William Hamilton
Journal:  Br J Gen Pract       Date:  2013-01       Impact factor: 5.386

Review 2.  Quality improvement through clinical communities: eight lessons for practice.

Authors:  Emma-Louise Aveling; Graham Martin; Natalie Armstrong; Jay Banerjee; Mary Dixon-Woods
Journal:  J Health Organ Manag       Date:  2012

Review 3.  The diagnosis of brain tumours in children: a guideline to assist healthcare professionals in the assessment of children who may have a brain tumour.

Authors:  Sophie Wilne; Karin Koller; Jacqueline Collier; Colin Kennedy; Richard Grundy; David Walker
Journal:  Arch Dis Child       Date:  2010-04-06       Impact factor: 3.791

4.  Progression from first symptom to diagnosis in childhood brain tumours.

Authors:  Sophie Wilne; Jacqueline Collier; Colin Kennedy; Anna Jenkins; Joanne Grout; Shona Mackie; Karin Koller; Richard Grundy; David Walker
Journal:  Eur J Pediatr       Date:  2011-05-20       Impact factor: 3.183

5.  Health and persistent functional late effects in adult survivors of childhood CNS tumours: a population-based cohort study.

Authors:  K K Boman; E Hovén; M Anclair; B Lannering; G Gustafsson
Journal:  Eur J Cancer       Date:  2009-07-16       Impact factor: 9.162

6.  Presentation of childhood CNS tumours: a systematic review and meta-analysis.

Authors:  Sophie Wilne; Jacqueline Collier; Colin Kennedy; Karin Koller; Richard Grundy; David Walker
Journal:  Lancet Oncol       Date:  2007-08       Impact factor: 41.316

7.  Pattern of symptoms and signs of primary intracranial tumours in children and young adults: a record linkage study.

Authors:  Thomas P C Chu; Anjali Shah; David Walker; Michel P Coleman
Journal:  Arch Dis Child       Date:  2015-06-04       Impact factor: 3.791

8.  The Aarhus statement: improving design and reporting of studies on early cancer diagnosis.

Authors:  D Weller; P Vedsted; G Rubin; F M Walter; J Emery; S Scott; C Campbell; R S Andersen; W Hamilton; F Olesen; P Rose; S Nafees; E van Rijswijk; S Hiom; C Muth; M Beyer; R D Neal
Journal:  Br J Cancer       Date:  2012-03-13       Impact factor: 7.640

9.  The National Awareness and Early Diagnosis Initiative in England: assembling the evidence.

Authors:  M A Richards
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

10.  Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study.

Authors:  Roger J Packer; James G Gurney; Judy A Punyko; Sarah S Donaldson; Peter D Inskip; Marilyn Stovall; Yutaka Yasui; Ann C Mertens; Charles A Sklar; H Stacy Nicholson; Lonnie K Zeltzer; Joseph P Neglia; Leslie L Robison
Journal:  J Clin Oncol       Date:  2003-09-01       Impact factor: 50.717

View more
  16 in total

Review 1.  Improving diagnosis of pediatric central nervous system tumours: aiming for early detection.

Authors:  Ran D Goldman; Sylvia Cheng; D Douglas Cochrane
Journal:  CMAJ       Date:  2016-11-28       Impact factor: 8.262

Review 2.  Improving early diagnosis of symptomatic cancer.

Authors:  Willie Hamilton; Fiona M Walter; Greg Rubin; Richard D Neal
Journal:  Nat Rev Clin Oncol       Date:  2016-07-26       Impact factor: 66.675

3.  Diagnostic delay in children with central nervous system tumors and the need to improve education.

Authors:  Ibrahim Qaddoumi; Thomas E Merchant; Fredrick A Boop; Amar Gajjar
Journal:  J Neurooncol       Date:  2019-11-05       Impact factor: 4.130

4.  Time to diagnosis of pediatric brain tumors: a report from the Pediatric Hematology and Oncology Center in Rabat, Morocco.

Authors:  Fatima Zahra Boutahar; Sarra Benmiloud; Maria El Kababri; Amina Kili; Mohamed El Khorassani; Nazik Allali; Mohamed Khattab; Ibrahim Qaddoumi; Laila Hessissen
Journal:  Childs Nerv Syst       Date:  2018-07-27       Impact factor: 1.475

5.  Factors associated with delayed diagnosis among Filipino pediatric brain tumor patients: a retrospective review.

Authors:  Patricia C Orduña; Cheryl Anne P Lubaton-Sacro
Journal:  CNS Oncol       Date:  2022-06-09

6.  Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care.

Authors:  Teresa de Rojas; Francisco Bautista; Miguel Flores; Lucía Igual; Raquel Rubio; Eduardo Bardón; Lucía Navarro; Laura Murillo; Raquel Hladun; Adela Cañete; Miguel Garcia-Ariza; Carmen Garrido; Ana Fernández-Teijeiro; Eduardo Quiroga; Carlota Calvo; Anna Llort; Inmaculada de Prada; Luis Madero; Ofelia Cruz; Lucas Moreno
Journal:  J Neurooncol       Date:  2017-12-16       Impact factor: 4.130

7.  Neurologic impairments from pediatric low-grade glioma by tumor location and timing of diagnosis.

Authors:  Zsila S Sadighi; Elizabeth Curtis; Jennifer Zabrowksi; Catherine Billups; Amar Gajjar; Raja Khan; Ibrahim Qaddoumi
Journal:  Pediatr Blood Cancer       Date:  2018-05-09       Impact factor: 3.167

8.  Initial symptoms and diagnostic delay in children with brain tumors at a single institution in Japan.

Authors:  Yuji Yamada; Daiki Kobayashi; Keita Terashima; Chikako Kiyotani; Ryuji Sasaki; Nobuaki Michihata; Toru Kobayashi; Hideki Ogiwara; Kimikazu Matsumoto; Akira Ishiguro
Journal:  Neurooncol Pract       Date:  2020-10-06

9.  Interventions to reduce the time to diagnosis of brain tumours.

Authors:  Robin Grant; Therese Dowswell; Eve Tomlinson; Paul M Brennan; Fiona M Walter; Yoav Ben-Shlomo; David William Hunt; Helen Bulbeck; Ashleigh Kernohan; Tomos Robinson; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2020-09-04

10.  Delays in diagnosis for children with newly diagnosed central nervous system tumors.

Authors:  Scott L Coven; Joseph R Stanek; Ethan Hollingsworth; Jonathan L Finlay
Journal:  Neurooncol Pract       Date:  2018-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.